Wang, Hui Qin <br/><br/>
Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human   [electronic resource] 

 -  eLife  04 2017 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2050-084X 
<br/><br/><label>Standard No.: </label>10.7554/eLife.17137  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaplastic Lymphoma Kinase<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm<br/>Heterografts<br/>Humans<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Neuroblastoma--drug therapy<br/>Proto-Oncogene Proteins c-mdm2--antagonists & inhibitors<br/>Pyrimidines--pharmacology<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Sulfones--pharmacology